Vesilute Peptide (20mg)

Vesilute, among dipeptides, exhibits a widespread presence in various bodily tissues, representing one of the less explored Khavinson peptides[1]. While it remains relatively understudied, Vesilute shows potential effects on bladder and genitourinary tissues. Reports from research suggest its ability to enhance bladder function, particularly in aging individuals, aiding in chronic cystitis, benign prostatic hyperplasia (BPH), and assorted urinary concerns. Its significant organotropic impact extends to the prostate, where it contributes to curbing cell proliferation and mitigating prostate enlargement, potentially attributed to enhanced microcirculation.